Mimicking of estradiol binding by flame retardants and their metabolites: A crystallographic analysis

Environmental Health Perspectives

Volumn 121, Issue 10, 2013, Pages 1194-1199

  Gosavi, Rajendrakumar A ^a   Knudsen, Gabriel A ^b   Birnbaum, Linda S ^b   Pedersen, Lars C ^a  

^a NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN SULFOTRANSFERASE; FLAME RETARDANT; POLYBROMINATED DIPHENYL ETHER; TETRABROMOBISPHENOL A;

ARTICLE; CHEMICAL STRUCTURE; CRYSTAL STRUCTURE; CRYSTALLIZATION; ENZYME INHIBITION; ENZYME SUBSTRATE COMPLEX; HORMONE BINDING; HUMAN; HYDROGEN BOND; METABOLITE; PRIORITY JOURNAL; PROTEIN CONFORMATION; PROTEIN EXPRESSION; PROTEIN PURIFICATION; X RAY CRYSTALLOGRAPHY;

CRYSTALLOGRAPHY, X-RAY; ESTRADIOL; FLAME RETARDANTS; POLYBROMINATED BIPHENYLS; SULFOTRANSFERASES;

EID: 84884899283     PISSN: 00916765     EISSN: 15529924     Source Type: Journal    
DOI: 10.1289/ehp.1306902     Document Type: Article

References (51)

1. Abdallah MA, Harrad S. 2011. Tetrabromobisphenol-A, hexa-bromocyclododecane and its degradation products in UK human milk: relationship to external exposure. Environ Int 37:443-448.
2. Adams PD, Afonine PV, Bunkóczi G, Chen VB, Davis IW, Echols N, et al. 2010. PHENIX: a comprehensive Python-based system for macromolecular structure solution. Acta Crystallogr D Biol Crystallogr 66:213-221.
3. Alaee M, Arias P, Sjödin A, Bergman Å. 2003. An overview of commercially used brominated flame retardants, their applications, their use patterns in different countries/regions and possible modes of release. Environ Int 29:683-689.
4. Birnbaum LS, Staskal DF. 2004. Brominated flame retardants: cause for concern? Environ Health Perspect 112:9-17; doi:10.1289/ehp.6559.
5. Blat Y. 2010. Non-competitive inhibition by active site binders. Chem Biol Drug Des 75:535-540.
6. BSEF (Bromine Science and Environment Forum). 2012. TBBPA Factsheet. Available: http://www.bsef.com/uploads/Documents/documents/Factsheet_TBBPA_25-10-2012.pdf [accessed 28 August 2013].
7. Chan WK, Chan KM. 2012. Disruption of the hypothalamic-pituitary-thyroid axis in zebrafish embryo-larvae following waterborne exposure to BDE-47, TBBPA and BPA. Aquat Toxicol 108:106-111.
8. Chen VB, Arendall WB III, Headd JJ, Keedy DA, Immormino RM, Kapral GJ, et al. 2010. MolPprobity: all-atom structure validation for macromolecular crystallography. Acta Crystallogr D Biol Crystallogr 66:12-21.
9. de Wit CA. 2002. An overview of brominated flame retardants in the environment. Chemosphere 46:583-624.
10. Emsley P, Lohkamp B, Scott WG, Cowtan K. 2010. Features and development of Coot. Acta Crystallogr D Biol Crystallogr 66:486-501.
11. Environment Canada/Health Canada. 2012. Risk Management Scope for Phenol, 4,4'-(1-methylethylidene) bis[2,6-dibromo-(Tetrabromobisphenol A). Chemical Abstract Service Registry Number (CAS RN): 79-94-7. Available: http://www.Ec.Gc.Ca/ese-ees/default.Asp?Lang=en&n=3bc8852b-1 [accessed 28 August 2013].
12. Falany CN. 1997. Enzymology of human cytosolic sulfotransferases. FASEB J 11:206-216.
13. Fini JB, Riu A, Debrauwer L, Hillenweck A, Le Mevel S, Chevolleau S, et al. 2012. Parallel biotransformation of tetrabromobisphenol A in Xenopus laevis and mammals: Xenopus as a model for endocrine perturbation studies. Toxicol Sci 125:359-367.
14. Gales L, Almeida MR, Arsequell G, Valencia G, Saraiva MJ, Damas AM. 2008. Iodination of salicylic acid improves its binding to transthyretin. Biochim Biophys Acta 1784:512-517.
15. Gamage N, Barnett A, Hempel N, Duggleby RG, Windmill KF, Martin JL, et al. 2006. Human sulfotransferases and their role in chemical metabolism. Toxicol Sci 90:5-22.
16. Gamage NU, Duggleby RG, Barnett AC, Tresillian M, Latham CF, Liyou NE, et al. 2003. Structure of a human carcinogen-converting enzyme, SULT1A1. Structural and kinetic implications of substrate inhibition. J Biol Chem 278:7655-7662.
17. Green J. 1996. Mechanisms for flame retardancy and smoke suppression-a review. J Fire Sci 14:426-442.
18. Hakk H, Larsen G, Bergman Å, Orn U. 2000. Metabolism, excretion and distribution of the flame retardant tetrabromobisphenol-A in conventional and bile-duct cannulated rats. Xenobiotica 30:881-890.
19. Hamers T, Kamstra JH, Sonneveld E, Murk AJ, Kester MHA, Andersson PL, et al. 2006. In vitro profiling of the endocrine-disrupting potency of brominated flame retardants. Toxicol Sci 92:157-173.
20. Hamers T, Kamstra JH, Sonneveld E, Murk AJ, Visser TJ, Van Velzen MJM, et al. 2008. Biotransformation of brominated flame retardants into potentially endocrine-disrupting metabolites, with special attention to 2,2',4,4'-tetrabromodiphenyl ether (BDE-47). Mol Nutr Food Res 52:284-298.
21. Johnson PI, Stapleton HM, Mukherjee B, Hauser R, Meeker JD. 2013. Associations between brominated flame retardants in house dust and hormone levels in men. Sci Total Environ 445-446:177-184.
22. Kakuta Y, Pedersen LG, Carter CW, Negishi M, Pedersen LC. 1997. Crystal structure of estrogen sulphotransferase. Nat Struct Mol Biol 4:904-908.
23. Kester MHA, Bulduk S, Tibboel D, Meinl W, Glatt H, Falany CN, et al. 2000. Potent inhibition of estrogen sulfotransferase by hydroxylated PCB metabolites: a novel pathway explaining the estrogenic activity of PCBs. Endocrinology 141:1897-1900.
24. Kester MHA, Bulduk S, van Toor H, Tibboel D, Meinl W, Glatt H, et al. 2002. Potent inhibition of estrogen sulfotransferase by hydroxylated metabolites of polyhalogenated aromatic hydrocarbons reveals alternative mechanism for estrogenic activity of endocrine disrupters. J Clin Endocrinol Metab 87:1142-1150.
25. Kester MHA, van Dijk CH, Tibboel D, Hood AM, Rose NJM, Meinl W, et al. 1999. Sulfation of thyroid hormone by estrogen sulfotransferase. J Clin Endocrinol Metab 84:2577-2580.
26. Koike E, Yanagisawa R, Takigami H, Takano H. 2012. Brominated flame retardants stimulate mouse immune cells in vitro. J Appl Toxicol; doi:10.1002/jat.2809 [Online 12 September 2012].
27. Mariussen E, Fonnum F. 2003. The effect of brominated flame retardants on neurotransmitter uptake into rat brain synaptosomes and vesicles. Neurochem Int 43:533-542.
28. Marteau C, Chevolleau S, Jouanin I, Perdu E, De Sousa G, Rahmani R, et al. 2012. Development of a liquid chromatography/atmospheric pressure photo-ionization high-resolution mass spectrometry analytical method for the simultaneous determination of polybrominated diphenyl ethers and their metabolites: application to BDE-47 metabolism in human hepatocytes. Rapid Commun Mass Spectrom 26:599-610.
29. National Toxicology Program. 2013. Pathology Tables, Survival and Growth Curves from NTP Short-Term and Long-Term Studies. TR-587: Tetrabromobisphenol A (TBBPA). Available: http://ntp.niehs.nih.gov/?objectid=1AF3931A-FF57-C2F8-3948D37883F3B052 [accessed 29 August 2013].
30. 2+ homeostasis. Toxicol In Vitro 22:943-952.
31. Otwinowski Z, Minor W. 1997. Processing of X-ray diffraction data collected in oscillation mode. In: Methods in Enzymology, Vol. 276 (Carter CWJ, Sweet RM, eds). New York:Academic Press, 307-326.
32. 137 in the sulfuryl transfer reaction. J Biol Chem 277:17928-17932.
33. Petrotchenko EV, Doerflein ME, Kakuta Y, Pedersen LC, Negishi M. 1999. Substrate gating confers steroid specificity to estrogen sulfotransferase. J Biol Chem 274:30019-30022.
34. Petrotchenko EV, Pedersen LC, Borchers CH, Tomer KB, Negishi M. 2001. The dimerization motif of cytosolic sulfotransferases. FEBS Lett 490:39-43.
35. Qiu X, Bigsby RM, Hites RA. 2009. Hydroxylated metabolites of polybrominated diphenyl ethers in human blood samples from the United States. Environ Health Perspect 117:93-98; doi:10.1289/ehp.11660.
36. Riu A, Grimaldi M, le Maire A, Bey G, Phillips K, Boulahtouf A, et al. 2011a. Peroxisome proliferator-activated receptor γ is a target for halogenated analogs of bisphenol A. Environ Health Perspect 119:1227-1232; doi:10.1289/ehp.1003328.
37. Riu A, le Maire A, Grimaldi M, Audebert M, Hillenweck A, Bourguet W, et al. 2011b. Characterization of novel ligands of ERα, ERβ, and PPARγ: the case of halogenated bisphenol A and their conjugated metabolites. Toxicol Sci 122:372-382.
38. Schauer UM, Volkel W, Dekant W. 2006. Toxicokinetics of tetrabromobisphenol A in humans and rats after oral administration. Toxicol Sci 91:49-58.
39. Shaw SD, Blum A, Weber R, Kannan K, Rich D, Lucas D, et al. 2010. Halogenated flame retardants: do the fire safety benefits justify the risks? Rev Environ Health 25:261-305.
40. Shen M, Cheng J, Wu R, Zhang S, Mao L, Gao S. 2012. Metabolism of polybrominated diphenyl ethers and tetrabromobisphenol A by fish liver subcellular fractions in vitro. Aquat Toxicol 114-115:73-79.
41. Shevtsov S, Petrotchenko EV, Pedersen LC, Negishi M. 2003. Crystallographic analysis of a hydroxylated polychlorinated biphenyl (OH-PCB) bound to the catalytic estrogen binding site of human estrogen sulfotransferase. Environ Health Perspect 111:884-888; doi:10.1289/ehp.6056.
42. Song WC. 2001. Biochemistry and reproductive endocrinology of estrogen sulfotransferase. Ann NY Acad Sci 948:43-50.
43. Stapleton HM, Eagle S, Sjödin A, Webster TF. 2012a. Serum PBDEs in a North Carolina toddler cohort: associations with handwipes, house dust, and socioeconomic variables. Environ Health Perspect 120:1049-1054; doi:10.1289/ehp.1104802.
44. Stapleton HM, Sharma S, Getzinger G, Ferguson PL, Gabriel M, Webster TF, et al. 2012b. Novel and high volume use flame retardants in US couches reflective of the 2005 PentaBDE phase out. Environ Sci Technol 46:13432-13439.
45. Sun M, Leyh TS. 2010. The human estrogen sulfotransferase: a half-site reactive enzyme. Biochemistry 49:4779-4785.
46. Tagliaferri S, Caglieri A, Goldoni M, Pinelli S, Alinovi R, Poli D, et al. 2010. Low concentrations of the brominated flame retardants BDE-47 and BDE-99 induce synergistic oxidative stress-mediated neurotoxicity in human neuroblastoma cells. Toxicol In Vitro 24:116-122.
47. Thomsen C, Lundanes E, Becher G. 2002. Brominated flame retardants in archived serum samples from Norway: a study on temporal trends and the role of age. Environ Sci Technol 36:1414-1418.
48. Visser TJ, van Buuren JCJ, Rutgers M, Rooda SJE, Deherder WW. 1990. The role of sulfation in thyroid-hormone metabolism. Trends Endocrin Metab 1:211-218.
49. Wang LQ, James MO. 2006. Inhibition of sulfotransferases by xenobiotics. Curr Drug Metab 7:83-104.
50. Zalko D, Prouillac C, Riu A, Perdu E, Dolo L, Jouanin I, et al. 2006. Biotransformation of the flame retardant tetrabromo-bisphenol A by human and rat sub-cellular liver fractions. Chemosphere 64:318-327.
51. Zhang H, Varlamova O, Vargas FM, Falany CN, Leyh TS. 1998. Sulfuryl transfer: the catalytic mechanism of human estrogen sulfotransferase. J Biol Chem 273:10888-10892.